Gene · 338557
FFAR4: free fatty acid receptor 4
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FFAR4: free fatty acid receptor 4. Genes, record 338557. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/338557
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q5NUL3 | Free fatty acid receptor 4 | 361 | 14 | Ensembl, GeneID, HGNC |
Source UniProt
Patents37
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026168538 A | 2026-08-13 | 2 | Q5NUL3 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 32891 | Q5NUL3 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 135862 | Q5NUL3 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 4001 | Q5NUL3 | Espacenet |
| JP 2020176846 A | 2020-10-29 | 10 | Q5NUL3 | Espacenet |
| US 10768184 B2 | 2020-09-08 | 9 | Q5NUL3 | Espacenet |
| US 10473673 B2 | 2019-11-12 | 9 | Q5NUL3 | Espacenet |
| US 10292374 B2 | 2019-05-21 | 87 | Q5NUL3 | Espacenet |
| US 10222387 B2 | 2019-03-05 | 9 | Q5NUL3 | Espacenet |
| JP 2017121240 A | 2017-07-13 | 52731 | Q5NUL3 | Espacenet |
1 to 10 of 37
See all 37 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants832
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FFAR4 papers | Newest fiscal year |
|---|---|---|---|
| P30DK063491 | Diabetes Research Center (DRC) | 6 | 2025 |
| P30DK020579 | Diabetes Research Center | 4 | 2025 |
| P30DK056341 | Washington University Nutrition Obesity Research Center | 3 | 2025 |
| P01CA196569 | Statistical Methods for Integrative Genomics in Cancer | 2 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 2 | 2025 |
| P30CA071789 | University of Hawaii Cancer Center CCSG | 2 | 2025 |
| P30DK019525 | University of Pennsylvania Diabetes Research Center | 2 | 2025 |
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 2 | 2025 |
| P30DK020593 | Vanderbilt Diabetes Research Center | 2 | 2025 |
1 to 10 of 832Source NIH's project files
See all 832 nih grantsPapers1,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decoding dietary fat: molecular sensing, brain integration, and the biology of flavor. | Can J Physiol Pharmacol | 2026 | 42826400 | PubTator, text mining | PubMed |
| Molecular mechanisms of lipid sensing in human cholecystokinin-secreting enteroendocrine cells. | Mol Metab | 2026 | 42805486 | PubTator, text mining | PubMed |
| Multi-population genome-wide association meta-analysis of acute and chronic pancreatitis. | medRxiv | 2026 | 42780122 | PubTator, text mining | PubMed |
| Antidepressant mechanism of sns in repairing synaptic damage via the GPR120/NLRP3 pathway-mediated inhibition of microglial M1 polarization. | Phytomedicine | 2026 | 42664588 | PubTator, text mining | PubMed |
Corrigendum to "Free-Fatty Acid Receptor-4 (FFA4/GPR120) differentially regulates migration, invasion, proliferation and tumor growth of papillary renal cell carcinoma cells" [Biochem. Pharmacol. 213 (2023) 115590]. | Biochem Pharmacol | 2026 | 42607359 | PubTator, text mining | PubMed |
| GPR120/free fatty acid receptor 4 (FFAR-4) agonists, antagonists, allosteric modulators: Computational drug design and discovery review. | Eur J Med Chem | 2026 | 42372394 | PubTator, text mining | PubMed |
| Spent Coffee Ground Extracts: A Sustainable Source of Antioxidant and Immunomodulatory Bioactives for Managing Lifestyle-Related Chronic Diseases. | Int J Mol Sci | 2026 | 42278504 | PubTator, text mining | PubMed |
| Modeling stimulus-induced stress responses in microglia-like cells using a commercial iPSC-dCas9-KRAB line. | Stem Cell Res | 2026 | 42214129 | PubTator, text mining | PubMed |
| Nmur1 and Cckar fail to support functional genetic access in adult dopamine neurons and challenge GPCR atlas assignments. | bioRxiv | 2026 | 42182265 | PubTator, text mining | PubMed |
| Impact of critical-site mutations in the free fatty acid receptor 4 on the allosteric kinetics of endogenous fatty acid-receptor interactions. | Anal Chim Acta | 2026 | 42108048 | PubTator, text mining | PubMed |
1 to 10 of 1,537
See all 1,537 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/338557
GET https://conductscience.org/api/genes/v1/338557/patents?page=2